Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DESVENLAFAXINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DESVENLAFAXINE EXTENDED-RELEASE TABLETS. DESVENLAFAXINE extended-release tablets, for oral use. Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)].
- generic_name
- desvenlafaxine succinate
- product_names
- Desvenlafaxine Succinate
- ndc
- 46708-540, 46708-541, 46708-542, 46708-540-17, 46708-540-30, 46708-540-90, 46708-540-31, 46708-540-91, 46708-540-10, 46708-540-80, 46708-541-17, 46708-541-30, 46708-541-90, 46708-541-31, 46708-541-91, 46708-541-10, 46708-541-80, 46708-542-30, 46708-542-90, 46708-542-31, 46708-542-91, 46708-542-10, 46708-542-80
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en